A型肉毒毒素与曲安奈德治疗瘢痕疙瘩的裸鼠模型对比研究
该研究将4例患者的瘢痕疙瘩组织植入28只无胸腺裸鼠,分别注射A型肉毒毒素、生理盐水或曲安奈德。结果显示治疗组与对照组组织重量差异有统计学意义(p<0.05),肉毒毒素组胶原束更少且Ki-67染色显著降低,提示A型肉毒毒素可能对瘢痕疙瘩有效。
要点
- A型肉毒毒素注射可减少瘢痕疙瘩组织重量和胶原束。
- 肉毒毒素组Ki-67增殖标志物染色显著低于对照组。
- 动物模型结果支持肉毒毒素作为瘢痕疙瘩潜在治疗选项。
核心结论
- A型肉毒毒素可能是治疗瘢痕疙瘩的有效方法。
研究设计与样本
- 基础科学动物模型,将4例患者的瘢痕疙瘩组织植入28只无胸腺裸鼠,每只小鼠植入3块组织。
- 植入1周后每个植入物分别注射A型肉毒毒素、生理盐水或曲安奈德,植入3周后取出组织分析。
主要发现
- 治疗前与治疗后组织重量配对t检验显示治疗组与对照组差异有统计学意义(p<0.05)。
- 盲法病理分析确认治疗组胶原束较少。
- Ki-67免疫组化显示治疗组染色显著减少。
临床怎么用
- 对于瘢痕疙瘩患者,A型肉毒毒素注射可能作为备选治疗方案,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Keloid scarring is a serious condition that mostly affects patients of African or Asian descent. Often disfiguring, this condition can have devastating psychosocial consequences. To date, no treatment modality has been proven ideal. The authors' objectives were (1) to determine the efficacy of botulin toxin type A injection for the treatment of keloid scars compared to steroid injection and to control saline injection (this was achieved through a basic science animal model using athymic nude mice and implanted human keloid tissue); and (2) to analyze the histopathologic changes that occur in an organized keloid scar following botulinum toxin type A injection as compared to steroid and saline injections. METHODS: Keloid scars from four patients were excised and implanted subcutaneously into 28 mice. Three small keloid tissue samples were implanted in each of the 28 mice. One week after implantation, each implant received one of three injections: botulinum toxin type A (treatment drug), saline (control), or steroid injection (first-line gold standard). The keloid tissue was extracted 3 weeks after implantation. Weight analysis, immunohistochemistry, and standard hematoxylin and eosin pathologic analysis were performed on each extracted tissue sample. RESULTS: Paired t test analysis of pretreatment and posttreatment tissue weights revealed a statistically significant difference between the treatment and control groups (p < 0.05). Analysis by a blinded pathologist confirmed fewer collagen bundles in the treatment group. Immunohistochemistry with Ki-67, a marker of cell proliferation, revealed significantly less staining in the treatment groups. CONCLUSION: Botulinum toxin type A could be an effective treatment for keloid scars.
引用
- Fanous A, Bezdjian A, Caglar D, et al. Treatment of Keloid Scars with Botulinum Toxin Type A versus Triamcinolone in an Athymic Nude Mouse Model. Plast Reconstr Surg. 2019. PMID: 30601323. doi:10.1097/PRS.0000000000005323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。